The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
8
Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.EBI
European Molecular Biology Laboratory
2
Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.EBI
University of Science and Technology
7
Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.EBI
Sejong University
10
Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis.EBI
Indiana University School of Medicine
1
Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity.EBI
Korea Research Institute of Bioscience and Biotechnology
50
Using small molecules to target protein phosphatases.EBI
Max Planck Institute of Molecular Physiology
1
Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agent.EBI
China Medical University
13
Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening.EBI
Sejong University
15
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors.EBI
Korea Research Institute of Chemical Technology
7
Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway.EBI
University of Pittsburgh
11
The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative.EBI
Shanxi University
8
Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.EBI
University of Pittsburgh
191
COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORSBDB
Augustine Therapeutics
11
Polyproline mimetics of proline-derived module-15BDB
Forschungsverbund Berlin
23
Pyrrolidine derivatives and their use as complement pathway modulatorsBDB
Novartis